Matthew B. Murphy - Net Worth and Insider Trading
Matthew B. Murphy Net Worth
The estimated net worth of Matthew B. Murphy is at least $137,921 dollars as of 2024-11-13. Matthew B. Murphy is the General Counsel of Nautilus Biotechnology Inc and owns about 55,390 shares of Nautilus Biotechnology Inc (NAUT) stock worth over $137,921. Details can be seen in Matthew B. Murphy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew B. Murphy has not made any transactions after 2022-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew B. Murphy
Matthew B. Murphy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew B. Murphy owns 1 companies in total, including Nautilus Biotechnology Inc (NAUT) .
Click here to see the complete history of Matthew B. Murphy’s form 4 insider trades.
Insider Ownership Summary of Matthew B. Murphy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NAUT | Nautilus Biotechnology Inc | 2022-08-15 | General Counsel |
Matthew B. Murphy Latest Holdings Summary
Matthew B. Murphy currently owns a total of 1 stock. Matthew B. Murphy owns 55,390 shares of Nautilus Biotechnology Inc (NAUT) as of August 15, 2022, with a value of $137,921.
Latest Holdings of Matthew B. Murphy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NAUT | Nautilus Biotechnology Inc | 2022-08-15 | 55,390 | 2.49 | 137,921 |
Holding Weightings of Matthew B. Murphy
Matthew B. Murphy Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew B. Murphy has made a total of 2 transactions in Nautilus Biotechnology Inc (NAUT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Nautilus Biotechnology Inc is the acquisition of 10,000 shares on August 15, 2022, which cost Matthew B. Murphy around $28,400.
Insider Trading History of Matthew B. Murphy
- 1
Matthew B. Murphy Trading Performance
GuruFocus tracks the stock performance after each of Matthew B. Murphy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew B. Murphy is -30.4%. GuruFocus also compares Matthew B. Murphy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew B. Murphy within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew B. Murphy's insider trading performs compared to the benchmark.
Performance of Matthew B. Murphy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.33 | | | | | |
| Relative Return to S&P 500(%) | -10.74 | | | | | |
Matthew B. Murphy Ownership Network
Ownership Network List of Matthew B. Murphy
Ownership Network Relation of Matthew B. Murphy
Matthew B. Murphy Owned Company Details
What does Nautilus Biotechnology Inc do?
Who are the key executives at Nautilus Biotechnology Inc?
Matthew B. Murphy is the General Counsel of Nautilus Biotechnology Inc. Other key executives at Nautilus Biotechnology Inc include Senior VP & Operations Mary E. Godwin , director & 10 percent owner & CEO & President & and Secretary Sujal M Patel , and Senior VP & Product Development Subramanian Sankar .
Nautilus Biotechnology Inc (NAUT) Insider Trades Summary
Over the past 18 months, Matthew B. Murphy made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net sale of 82,031 shares made by Mary E. Godwin , and a net purchase of 50,000 shares made by Sujal M Patel .
In summary, during the past 3 months, insiders sold 82,031 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 0 shares, with a net sale of 82,031 shares. During the past 18 months, 82,031 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 32,031 shares.
Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nautilus Biotechnology Inc Insider Transactions
Matthew B. Murphy Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew B. Murphy. You might contact Matthew B. Murphy via mailing address: C/o Nautilus Biotechnology, Inc., 425 Pontius Ave N, Ste 202, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
